Vancouver

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Amyloidosis3 trials
• Dermatomyositis and polymyositis (myositis)1 trial
• Huntington's disease1 trial
• Obesity1 trial
• Prostate cancer1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 34 trials
• Phase 12 trials
• Phase 1/21 trial

Status

• Completed3 trials
• Recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• Alnylam Pharmaceuticals5 trials
• Arvinas Androgen Receptor, Inc.1 trial
• Priovant Therapeutics, Inc.1 trial

Running trials

• Recruiting

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  NCT07223203· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Alnylam Pharmaceuticals· Source

• Active, not recruiting

  A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

  NCT06845202· Phase 1/2· Alnylam Pharmaceuticals· Source

• Recruiting

  A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease

  NCT06585449· Phase 1· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis2 recruiting
• Huntington's disease1 recruiting

Closed trials

• Completed

  A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

  NCT05437263· Phase 3· Priovant Therapeutics, Inc.· Source

• Completed

  Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer

  NCT05177042· Phase 1· Arvinas Androgen Receptor, Inc.· Source

• Completed

  HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

  NCT03759379· Phase 3· Alnylam Pharmaceuticals· Source